Navigation Links
Researchers develop powerful tool to study the genetics of inflammation
Date:11/30/2007

WINSTON-SALEM, N.C. Scientists have known which genes are linked to inflammation, but now researchers at Wake Forest University Baptist Medical Center have organized this information to develop a powerful tool to aid investigators in studying the genetics of inflammatory diseases.

Using complex web-based software called Ingenuity Pathway Analysis, the researchers were able to systematically map out pathways, or chains of genes, and subpathways that contribute to various aspects of inflammation.

We basically organized the inflammation-associated genes in a systematic way, said Matthew Loza, Ph.D., of the Center for Human Genomics at Wake Forest University School of Medicine, and lead author of the study. Before, a random list of genes involved in inflammation was all you had. We started with that same list, but then built these networks to bring all these different genes together.

The study, which was recently published by the Public Library of Science in its online journal PLoS One, has also led to the development of two customized panels for analyzing genetic variations in the inflammation pathways -- one for European and one for African descent populations. In a laboratory, these panels are analyzed using special laboratory equipment and computer systems. Researchers can obtain the custom inflammation panel through Affymetrix Corporation.

This is so significant because inflammation is a very hot topic, and many research groups want to study it, said Bao-Li Chang, Ph.D., assistant professor of pediatrics at Wake Forest and senior author for the study. We have provided researchers with the tool to effectively and efficiently accomplish their goals.


'/>"/>

Contact: Karen Richardson
krchrdsn@wfubmc.edu
336-716-4453
Wake Forest University Baptist Medical Center
Source:Eurekalert

Page: 1

Related medicine news :

1. Stanford researchers find culprit in aging muscles that heal poorly
2. UCLA researchers identify markers that may predict diabetes in still-healthy people
3. Mayo Clinic researchers discover new diagnostic test for detecting infection in prosthetic joints
4. Bipolar disorder relapses halved by Melbourne researchers
5. Cell that triggers symptoms in allergy attacks can also limit damage, Stanford researchers find
6. High and mighty: first common height gene identified by researchers behind obesity gene finding
7. Researchers estimate about 9 percent of US children age 8 to 15 meet criteria for having ADHD
8. Majority of 2.4 Million U.S. Children With ADHD Not Diagnosed or Consistently Treated, According to New Gold Standard Study by Cincinnati Childrens Researchers
9. Researchers develop long-lasting growth hormone
10. Jefferson immunology researchers halt lethal rabies infection in brain
11. Purdue researchers develop technology to detect cancer by scanning surface veins
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2008)...holders to be held on January 8, 2009 , , T... International Inc. ("MedEmerg") (OTCBB: MDER), on..., announced today that it has obtained an interim ...oncerning its previously announced plan of arrange...lth Group Inc. ("AIM") will acquire all of MedEmer...
(Date:11/21/2008)...he University of Texas Health Science Center at Ho...ce in Aging Studies (TEXAS), to promote geriatrics...million award from the Donald W. Reynolds Foundati...ll allow us to teach geriatric medicine principles...to practicing physicians. With the reach of Lyndon...
(Date:11/21/2008)... Heska Corporation,(Nas...he New York Society of,Security Analysts, 12th An...ecember 2, 2008 at 1177 Avenue of the Americas, 2n...duled to begin at 9:35 a.m. Eastern Time (7:35 a.m...ebcast and for two weeks,following the presentati...
(Date:11/21/2008)... The Generic,Pharmaceut...tement today from,GPhA President and CEO Kathleen...TC) roundtable on "Emerging Health Care Competitio...at the FTC is conducting this roundtable demonstra...sumers have access to safe and,affordable biogene...
Breaking Medicine News(10 mins):Health News:Med-Emerg International Inc. obtains interim court order for plan of arrangement with AIM Health Group Inc. 2Health News:Med-Emerg International Inc. obtains interim court order for plan of arrangement with AIM Health Group Inc. 3Health News:UT Houston launches geriatric training with $3.25 million in grant, matching funds 2Health News:UT Houston launches geriatric training with $3.25 million in grant, matching funds 3Health News:UT Houston launches geriatric training with $3.25 million in grant, matching funds 4Health News:GPhA Statement on FTC Roundtable on Biogenerics 2
...A new study suggests that children with hemophilia...ses joint pain and swelling, are more at risk // ... their later years. But there is hope in preventi...dren, say researchers. Hemophiliac children are no...
...Eighty percent of the time childhood acute lymphob...bad news is doctors are not sure // why it doesn’...new research finds it could be because of a small ...rugs used to treat the disease. Researchers teste...
...A new study finds MRIs are significantly better at...ping cancers than standard mammograms // or clinic...omen with a lifetime breast cancer risk of 15 perc...so carried one of the genes known to put women at ...
...Moms-to-be have one more good reason not to smoke....ing during the early months // of pregnancy increa...e study, involved women from Scotland and England ...ere about six months old. Researchers asked about ...
Other Medicine News:
(Date:11/20/2008)... WASHINGTON, Nov. 20 T...h & Gender Equity: , , WHAT: World AI... , Tuesday, November 25, 2008 , 11:00 a.m. E...trongly encouraged: https://cc.readytalk.com/r/1x...ions outpacing the number of people newly put on t...
(Date:11/20/2008)... , , , , PHILADELPHIA, Nov. 20 /P...K ) today announced that the United States Food an...proval for PROMACTA(R) (eltrombopag) for the treat...immune (idiopathic) thrombocytopenic purpura (ITP)...teroids, immunoglobulins or splenectomy. The appro...
(Date:11/20/2008)... REINACH, Switzerland, November 20 /PRNewswir...y that the Anti-infective Drugs Advisory Committee...as voted 17 to 2 against the,approval of intraven...nt for,the treatment of patients with complicated...luding those caused by methicillin-resistant Staph...
(Date:11/20/2008)... EMERYVILLE, Calif., Nov. 20 /PRNewswire-FirstCal...he company will present results from the Phase 1B,...dvanced metastatic breast,cancer, BZL101, at the ...onal,Conference in Atlanta, Georgia. The Company...g abstract and will be presented as a part of the ...
Breaking Medicine Technology:Faith and Civil Society Leaders Call for Truth and Leadership in U.S. HIV Prevention Efforts 2FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 2FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 3FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 4FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 5FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 6FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 7FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 8Arpida Comments on FDA's Anti-infective Drugs Advisory Committee Outcome 2Arpida Comments on FDA's Anti-infective Drugs Advisory Committee Outcome 3Arpida Comments on FDA's Anti-infective Drugs Advisory Committee Outcome 4Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 2Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 3Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 4Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 5Minnesota Reaches Milestone in Goal to End Homelessness 28155 1Minnesota Reaches Milestone in Goal to End Homelessness 28155 2NovoLogix Launches First Annual Symposium for Healthcare Thought Leaders 28151 1NovoLogix Launches First Annual Symposium for Healthcare Thought Leaders 28151 2NovoLogix Launches First Annual Symposium for Healthcare Thought Leaders 28151 3Men are better at detecting infidelities 5647 1Men are better at detecting infidelities 5647 2Women at Higher Risk for Pulmonary Hypertension 28144 1Women at Higher Risk for Pulmonary Hypertension 28144 2
...FORT LEE, N.J.--(BUSINESS WIRE)--Jun 21, 2007 - Ne...blication in the June 23 issue,of the journal The ...e therapy trial for Parkinson,s disease and the fi...s own brain cells for any adult,neurodegenerative ...in 12 patients with,advanced Parkinson,s disease d...
..."Electroloading of mature dendritic cells with tum...ponse", GAITHERSBURG, Md., and YOKOHAMA, Japan, Ju...net Co., Ltd. announce a,joint poster presentation...ociety for Cellular Therapy. The meeting is being,...presentation is entitled "Electroloading of mature...
Other Medicine Technology:Neurologix Announces Publication of Landmark Gene Therapy Study,Demonstrating Safety and Statistically Significant Improvement in,Patients With Advanced Parkinson's Disease 2Neurologix Announces Publication of Landmark Gene Therapy Study,Demonstrating Safety and Statistically Significant Improvement in,Patients With Advanced Parkinson's Disease 3Neurologix Announces Publication of Landmark Gene Therapy Study,Demonstrating Safety and Statistically Significant Improvement in,Patients With Advanced Parkinson's Disease 4Neurologix Announces Publication of Landmark Gene Therapy Study,Demonstrating Safety and Statistically Significant Improvement in,Patients With Advanced Parkinson's Disease 5Neurologix Announces Publication of Landmark Gene Therapy Study,Demonstrating Safety and Statistically Significant Improvement in,Patients With Advanced Parkinson's Disease 6MaxCyte and Medinet to Present at the 13th Annual Meeting of the,International Society for Cellular Therapy (ISCT) in Sydney,Australia 2MaxCyte and Medinet to Present at the 13th Annual Meeting of the,International Society for Cellular Therapy (ISCT) in Sydney,Australia 3
This is adapted to microplate or card.
ScanGel® Incubator
The ID-Micro Typing System™ (ID-MTS) Gel Test is suitable for a broad range of blood bank applications. Applications that include antibody screening and identification, ABO blood grouping and R
...Mini-Vertical Gel System simplifies the process of...AGE format. It is able to run four gels at a time,...tility and throughput, the 120 mini-vertical runs ...120 mini-vertical has a modular design. The basic ...
Medicine Products: